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Abstract 
 
Lectin’s are proteins capable of recognising and binding to specific oligosaccharide 
structures found on glycoproteins and other biomoloecules. As such they have found 
utility for glycoanalytical applications. One common difficulty encountered in the 
application of these proteins, particularly in multi-well plate assay formats known as 
Enzyme Linked Lectin Assays (ELLA’s), is in finding appropriate blocking solutions 
to prevent non-specific binding with plate surfaces. Many commonly used blocking 
agents contain carbohydrates and generate significant background signals in ELLA’s, 
limiting the utility of the assay.  
 
In this study we examined the suitability of a range of blocking reagents, including 
protein based, synthetic and commercially available carbohydrate free blocking 
reagents, for ELLA applications. Each blocking reagent was assessed against a panel 
of 19 commercially available biotinylated lectins exhibiting diverse structures and 
carbohydrate specificities. We identified the synthetic polymer Polyvinyl Alcohol 
(PVA) as the best global blocking agent for performing ELLA’s. We ultimately present 
an ELLA methodology facilitating broad spectrum lectin analysis of glycoconjugates 
and extending the utility of the ELLA. 
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Introduction 
 
Many proteins are subject to post translation modifications (PTM’s) and these 
modifications have significant effects on the biological properties and functions of 
proteins. Of all of the potential PTM’s that occur in cells glycosylation, which results 
in the addition of oligosaccharide moieties to proteins, is one of the most abundant and 
biologically significant (1-3). Oligosaccharide structures are also found attached to 
other cellular macromolecules such as lipids, and include molecules such as 
lipopolysaccharides (LPS and LOS) of bacterial cell membranes, GPI proteins and 
glycosphingolipids found in eukaryotic cell membranes (3, 4). Glycans, therefore, 
constitute an important interface between a cell and its environment and play important 
roles in molecular recognition, usually through interactions with specific carbohydrate-
binding proteins called lectins (5-7). As molecular recognition molecules, glycans 
mediate a vast array of biological processes including cell development and 
differentiation, cell adhesion and migration, innate and adaptive immune responses, 
cell proliferation and apoptosis, interactions between cells and soluble ligands (cell 
signaling), and between cells and various infectious agents such as prions, viruses and 
microorganisms (1, 8-10). Our ability to understand such complex biological process 
therefore necessitates techniques enabling the analysis of glycoproteins and other 
glycoconjugates. 
 
Glycans exhibit greater structural diversity than other cellular macromolecules and 
often form highly complex branched structures. Their capacity to generate such 
diversity stems from the fact that oligosaccharide structures can (1) vary in terms of the 
sequence in which monosaccharide subunits are linked (2) the positions of linkages 
resulting in branching and the extent of branching (3) the anomeric configuration of 
linkages (α or β configurations)  and  (4)  the  presence  or  absence  of  additional  
modifications  such  as sulphonation (11). This capacity for structural and 
conformational diversity facilitates their role in expanding the diversity of biological 
systems, and their roles in molecular recognition, but the analysis of such complex and 
diverse molecules presents a significant technical challenge. Unfortunately, the 
development of glycoanalytical techniques lagged significantly behind the 
technological advances experienced in the fields of genomics and proteomics. 
However, as our appreciation for the biological significance of glycan’s has grown the 
development of glycoanalytical techniques has accelerated and methods now exist that 
allow the detailed characterization of glycoconjugates. These include HPLC, mass 
spectrometry (MS), Nuclear Magnetic Resonance (NMR) and combinatorial 
methodologies (12-18). However, such techniques usually require expensive 
specialized equipment, as well as highly skilled personnel, and as such these methods 
are not always widely accessible to all. Analysis requires chemical or enzymatic 
removal of glycan’s followed by their derivatization with fluorescent markers to enable 
their subsequent detection. These glycan removal and derivatization steps often require 
optimization, increase analysis times and analysis can require large sample quantities 
(4, 19, 20). There is therefore an urgent requirement for the development of more 
simplistic and accessible methods for glycoprotein and glycoconjugate analysis. 
 
Lectins are carbohydrate binding proteins (CBP’s) capable of recognizing and binding 
to specific glycan structures. An increasing number of lectins, particularly from plant 
and animal sources, have been characterised with respect to their glycan binding 
specificity and a large number of such lectins are now commercially available (see 
Table 1). The ability of lectins to discriminate between different glycan structures 
makes them useful tools for performing glycoanalysis. Using panels of lectins, of 
known glycan binding specificities, lectin binding patterns (fingerprints) can be 
obtained that are indicative of the glycosylation status of a glycoprotein or 
glycoconjugate (21-23). One of the key advantages of using lectins is that analysis can 
be performed without the need for initial glycan removal and derivatization thereby 
greatly simplifying analysis.  
 
Lectins can be implemented for glycoanalysis in a number of different formats 
including lectin microarray techniques (21-25). However, the most simplistic format in 
which lectins can be employed for glycoanaylsis is the Enzyme-Linked Lectin Assay 
(ELLA). This assay has the same basic format as a standard ELISA (see Figure 1) and 
allows the analysis of glycoproteins, and lectin-glycan interactions, in a standard 
microtitre plate format. The most common format of the ELLA requires the 
immobilization of glycoconjugates on the surface of an ELISA plate, subsequent 
blocking of the plate surface and then probing with biotinylated lectins (26). The major 
problem that is encountered when performing the ELLA stems from the lack of 
suitable blocking reagents. Many of the blocking reagents traditionally used in ELISA 
are unsuitable for use in ELLA as they generate high background signals, contributing 
to false-positive signals, due to the presence of carbohydrate in the preparations (26-
29). As a result of these difficulties many of the ELLA protocols reported in the 
literature to date have only utilized small and specific subsets of lectins (30-32) and 
their utility is thereby restricted. In this paper we have examined the suitability of a 
number of blocking agents for broad spectrum lectin analysis in an ELLA format. 
Ultimately we describe an optimized ELLA methodology that allows the assay to be 
performed with a broad spectrum of lectins, of diverse glycan binding specificities, 
thereby extending and enhancing its utility and providing a broadly accessible and 
simple assay for glycoanalysis.  
 
Abbreviations 
BSA, bovine serum albumin; ELLA, enzyme-linked lectin assay; HRP, Horse Radish 
Peroxidase; PBS, phosphate buffered saline; PEG; polyethelene glycol; PVA, 
polyvinyl alcohol; PVP, Polyvinylpyrrolidone; TBS, tris buffered saline; TBST, tris 
buffered saline supplemented with 0.05% Tween-20; TMB, 3,3′,5,5′-
Tetramethylbenzidine; Lectins are listed in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
 
Materials 
 
Biotinylated lectins, agarose immobilized lectins and Carbo-Free Blocking (Product 
code SP-4050) were purchased from Vector Laboratories (Peterborough, UK). Bovine 
serum albumin (BSA) was obtained from Sigma Aldrich. Three grades were used in 
this study: product A9647 is described as having 96% purity (BSA96), product A7906 
is described as being 98% purity (BSA98) and product A7030, also described as being 
98% purity, is suitable for use in ELISA (ELISA Grade BSA). The BSA routinely used 
was BSA98 unless otherwise stated. Synblock was purchased from AbD Serotec 
(Oxford, UK). The glycoproteins Bovine Fetuin, Invertase (from Saccharomyces 
cerevisiae) and porcine Thyroglobulin used in this study were obtained from Sigma 
Aldrich. All other chemicals, including L-fucose, methyl α-D-mannopyranoside, HRP-
conjugated anti-biotin, polyvinyl alcohol (molecular weight, 50,000), 
Polyvinylpyrrolidone (molecular weight, 360,000), PEG 8,000 and PEG 20,000 and 
TMB were also obtained from Sigma–Aldrich–Fluka (St. Louis, MO, USA). 
Polystyrene microtiter plates (Nunc MaxiSorp) were purchased from Thermo Fisher 
Scientific, Roskilde, Denmark. 
 
 
Methods 
 
Enzyme-Linked Lectin Assays (ELLA’s). 
 
Although certain assay parameters were varied throughout this series of experiments, 
the basic protocol followed is described here. Glycoprotein immobilization was 
performed by adding 50 µL of a glycoprotein solution to the wells of an ELISA plate 
and incubating overnight at 4oC. Glycoprotein solutions used were prepared by 
dissolving a glycoprotein, typically at a concentration of 10mg mL-1, in 10 mM sodium 
phosphate buffer pH7.2 containing 150 mM NaCl (PBS). For negative control wells 50 
µL of PBS was added. These wells would be used to monitor for cross reactivity of 
lectins, or detection anti-bodies, with plate surfaces that would generate background 
signals. All subsequent steps were performed at 25oC. The glycoprotein solution was 
removed by inversion, 150 µL of a blocking solution was added to all wells and the 
plate was left to block for 2 hours. The wells were washed four times with 20 mM Tris 
pH 7.6, 150 mM NaCl,  0.05% Tween-20  supplemented with 1 mM CaCl2, 1 mM 
MnCl2, 1 mM MgCl2 (TBST).  Lectin solutions were prepared in TBST, 50 µL was 
added to each well and the plates were incubated for 1 hour. When inhibition assays 
were performed, lectins were pre-incubated with the sugar under investigation for 15 
minutes prior to application to plates. Unbound lectin was removed by washing each 
well four times with TBST before the addition of 50 µl of 1:10 000 diluted HRP 
labeled anti-biotin antibody for 1 hour. Plates were subsequently washed four times 
with TBST followed by one final wash with PBS. TMB solution was prepared 
according to the supplier’s instructions. 100 µL TMB was added to each well and the 
reaction was stopped with 50 µl 10% H2SO4 after 10 min. The absorbance was 
measured at 450 nm using a BioTek ELx808 plate reader. 
 
 
Preparation of Blocking Solutions For ELLA’s 
 
BSA blocking solutions were prepared as 3% solutions in TBS. Deglycosylated BSA 
(deBSA) was prepared by sodium periodate oxidation (33). This was prepared by 
dissolving 5% BSA and 50mM sodium periodate in 50mM sodium acetate, pH 4.0, and 
incubating with rotation for 2 hours in the dark at 4oC. The deBSA solution was 
dialysed into TBS overnight with three changes of buffer prior to use in ELLA’s. PVA 
and PVP were prepared by dissolving in heated PBS. PEG solutions were prepared by 
dissolving in water. All blocking solutions, with the exception of deBSA, were 
prepared directly before use. 
 
Lectin Affinity Purifications – Pull Down Assays. 
 
Lectin affinity purifications were performed using ConA-agarose and AAL-agarose. 
These lectin affinity resins were equilibrated prior to use by washing with TBST. 
Purifications were performed in the form of pull down assays whereby 100µl of an 
equilibrated lectin agarose resin was mixed with 1 mL of a BSA98 solution (5 mg.mL-1 
in TBST) and the suspension left to mix by inversion overnight.  The suspension was 
then centrifuged at a low speed of 5000g for 2 minutes to sediment the lectin agarose 
resin and any bound glycoproteins. The supernatant, containing unbound proteins, was 
then recovered and retained for later analysis. Prior to the elution of bound proteins, 
the lectin resin was washed four times with TBST. Bound glycoproteins were then 
selectively eluted by the addition of 100µl of 200 mM α−methyl-mannose or 100 mM 
L-fucose to ConA-agarose and AAL-agarose respectively. Suspensions were left 
incubating for 1 hour, to permit efficient elution of bound glycoproteins, and then 
centrifuged as before. Supernatants, containing sugar eluted glycoproteins, were 
recovered and retained for later analysis. Residual bound proteins, that had not been 
successfully eluted from the lectin resins, were recovered by applying a final 
denaturing elution step. This was achieved through the addition of 50µl of SDS-PAGE 
loading buffer to the resin and boiling for 5 mins. Again samples were ultimately 
centrifuged to sediment residual insoluble material and the supernatant, containing 
solublized denatured proteins, was recovered for later analysis. Samples taken at each 
step in the pull down assays were run on 10% SDS-PAGE gels (34). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
Evaluation of BSA as a Blocking Reagent for use in ELLA Protocols. 
 
BSA is the most commonly used blocking agents used in ELISA methods and its use 
in ELLA’s has also been reported (24, 35). We evaluated the suitability of BSA for use 
as a blocking agent in broad spectrum lectin screens (6, 36). To do this 150 µl of a 3% 
BSA solution was added to pre-rinsed wells for 1 hr to block the wells.  The wells were 
then probed with biotinylated lectins to monitor for interactions with the BSA coated 
surfaces. Of the 19 lectins tested, 9 of them were observed to exhibit strong 
interactions with the BSA blocked surfaces (see Figure 2). In particular, sialic acid 
binding lectins WGA, MalII and SNA showed very strong responses as did the 
mannose specific lectins ConA and LCA. The binding of such sugar specific subsets of 
lectins, and such a range of structurally diverse lectins, was suggestive that the high 
background signals observed were due to specific lectin-glycan interactions with the 
BSA blocked plate surfaces and not simply due to non-specific protein-protein 
interactions. The signals observed for many of these lectins, which included some of 
the most commonly used lectins and key glycan specificities, were of such a magnitude 
that it would preclude their use in ELLA assays using BSA as a blocking agent. We 
therefore sought to verify the basis for the high background signals observed with the 
intention of finding an ultimate solution to overcome this issue. 
 
 
Lectin Interactions with BSA Blocked Plate Surfaces are due to Specific Lectin-
Glycan Interactions. 
 
Sugar inhibition assays were performed to establish whether the lectin interactions 
observed with BSA blocked wells were due to protein-protein interactions or more 
specific lectin-glycan interactions. Lectins displaying strong interactions with the BSA 
blocked wells were chosen for this experiment. In each case, when the lectins were 
pre-incubated with their preferred sugar ligand, binding to BSA blocked plate surfaces 
was completely suppressed. Conversely, when lectins were pre-incubated with a non-
binding sugar, significant binding of the lectins to BSA blocked plate surfaces was still 
observed (see Figure 3). These results clearly demonstrated that many of the observed 
lectin interactions with the BSA blocked plate surfaces were due to specific lectin-
glycan interactions and not due to non-specific protein-protein interactions. 
 
 
Lectin Interactions with BSA Blocked Plate Surfaces are due to the Presence of 
Contaminating Glycoproteins in BSA Preparations.  
 
It is known that BSA is not itself a glycosylated protein (37). It was therefore proposed 
that the lectin interactions with BSA blocked surfaces may be due to the presence of 
contaminating glycoproteins in the BSA preparation. To verify this we performed 
lectin affinity pull down assays on BSA preparations. These were performed with two 
of the lectins that had displayed the strongest interactions with BSA blocked wells, 
ConA-Agarose and AAL-Agarose. Using these lectin affinity resins we were able to 
isolate and concentrate contaminants in the BSA98 preparation. When lectin bound 
proteins were eluted from the ConA agarose resin and run on SDS-PAGE, multiple 
bands were clearly evident (see Figure 4). While fewer bands were visible in the eluted 
fraction of proteins from the AAL-agarose, most of those that were present were also 
visible in the ConA eluted pool. This clearly demonstrated the presence of specific 
contaminating glycoproteins in BSA98 preparations.  
 
Having verified that the observed interactions of lectins with BSA blocked wells were 
due to contaminants in the BSA we decided to examine several different purity grades 
of commercially available BSA. We wanted to determine how the different levels of 
purity would impact on the observed interactions of the lectins and if a specific 
commercially available BSA preparation could be identified for specific application in 
ELLA’s. Three different commercially available BSA preparations were compared: 
96% BSA (BSA96), 98% BSA (BSA98) and ELISA grade BSA. Many of the lectins 
showed very strong signals on all of the purity grades of BSA although the signals on 
the ELISA grade BSA were generally slightly lower than those obtained for plates 
blocked with the BSA96 and BSA98 (see Figure 5).  While the signals on the ELISA 
grade BSA were generally lower, this grade of BSA would still be unsuitable for 
ELLA analysis. 
 
 
 
Oxidative Deglycosylation of BSA Preparations – Cost Effective Generation of a 
Suitable Blocking Agent. 
 
Having verified that the observed interactions of lectins with BSA blocked wells was 
due to specific interactions with contaminating glycoproteins in BSA preparations we 
sought to try and overcome this by performing a bulk deglycosylation of BSA 
preparations. This was achieved by treatment of BSA preparations with sodium 
periodate to oxidize any sugars present. Interactions of both untreated BSA and 
deglycosylated BSA (deBSA) with biotinylated lectins were compared by ELLA. As 
can be seen from Figure 6, the periodate treatment did appear to eliminate the 
reactivity of most lectins with BSA blocked wells, confirming that most of the lectins 
observed to interact with the BSA blocked wells had done so in a sugar specific 
fashion. However, four of the lectins, AIA (Jacalin), DSL, WGA, and to a lesser extent 
GSLI, did still generate significant signals against wells blocked with the deBSA.  
 
 
Evaluation of ELLA Protocols Omitting Plate Surface Blocking Steps 
 
Duk et al reported an ELLA protocol whereby the wells of ELISA plates were coated 
with glycoprotein (or a glycoconjugate) solutions and biotinylated lectins were added 
directly to the wells without a prior blocking step (26). They reported that once Tween-
20 was included in the lectin solution, absorbance readings in lectin control wells, with 
no immobilized glycoprotein, was low. However this was only demonstrated for a 
relatively small set of lectins, all of which had Gal/GalNAc specificity. We therefore 
sought to evaluate this method for use with a broader range of lectins.  ELISA plates 
were rinsed with PBS, to mimic the ‘no glycoprotein’ negative control wells of an 
ELLA, and then washed with TBST. A range of biotinylated lectin solutions was 
prepared at concentrations of 1-5 µg.mL-1 in TBST, and added directly to the plate. 
Although many of the lectins tested did not generate significant signals, some, did 
exhibit clearly detectable signals indicating a capacity to interact non-specifically with 
unblocked plate surfaces under the assay conditions used (see Figure 5). Again, some 
of the most commonly used lectins, such as AAL, ConA, AIA and DSL, gave 
extremely high signals of such a magnitude that they would not be suitable for use in 
ELLA’s performed using this methodology.  
 
Investigation of Synthetic Blocking Reagents 
 
Having determined that ELLA strategies either omitting plate surface blocking steps or 
using BSA as a blocking agent were unsuitable for broad spectrum lectin screens, we 
investigated a number of synthetic polymers as blocking agents. The reagents 
investigated were 0.5% PVA, 0.5% PVP, 1% PEG 8,000 and 1% PEG 20,000 
solutions. In an initial experiment these were used to coat the wells of ELISA plates 
prior to the addition of biotinylated lectins which were prepared in TBST as usual. 
Only those lectins that had been observed to exhibit high backgrounds in other 
blocking strategies were examined initially. As can be seen from the results obtained 
(see Figure 7A) PVA performed the best with all of the lectins tested giving very low 
background signals of 0.1 or lower.   
 
To further evaluate the suitability of PVA as a blocking agent it was used in an ELLA 
analysis of a number of standard commercially available glycoproteins. The 
glycoproteins Fetuin, Invertase and Thyroglobulin were immobilized in the wells of 
ELISA plates by overnight incubation at 4oC. Wells were washed as usual and then 
blocked with 0.5% PVA. Each glycoprotein was then probed with a broad spectrum of 
lectins (see Figure 7B). Each lectin was added at a concentration of 5 µg.mL-1 and all 
of the lectins showed negligible signals in negative control wells in which there was no 
immobilized glycoproteins. Each of the lectins tested was however observed to interact 
with the glycoproteins in an expected fashion based on the glycan structures known to 
be present on these glycoproteins. For example, the sialic acid binding lectins showed 
high signals on Fetuin (38) and Thyroglobulin (39), but did not interact with Invertase 
(40). Conversely, terminal mannose binding lectins interacted strongly with Invertase, 
but not with Fetuin. ConA and LCA, which are known to bind to N-linked glycans, 
showed binding to all of the glycoproteins. These results indicated that while the PVA 
prevented non-specific interactions with the plate surface it did not interfere with the 
ability of the lectins to interact with the immobilized glycoproteins. PVA can therefore 
be used as a blocking agent enabling ELLA analysis of glycoproteins to be performed 
using a very broad spectrum of lectins thereby achieving more in-depth glycoanalysis 
of target glycoproteins.  
 
 
Comparison of PVA versus Commercial Carbohydrate Free Blocking Agents. 
 
The final blocking solutions tested were two commercially available ELISA blocking 
reagents Synblock (AbD Serotec) and Vector Laboratories’ Carbo-Free blocking 
solution. PVA solution was included in the experiment for comparison. Synblock 
proved to be an excellent blocking reagent and gave identical results to the PVA 
blocked wells. Surprisingly, several of the lectins tested interacted with the Carbo-Free 
blocker, including AIA, MAL II, SNA, DSL, WGA and SBA (Figure 9). Since this 
blocking solution does not contain carbohydrate the interactions must be due to 
protein-protein interactions. 
 
 
 
 
Signal Quenching by Inclusion of BSA in Lectin Probing Solutions 
 
In addition to being used as a blocking agent BSA is traditionally included in antibody 
probing solutions in ELISA’s to reduce non-specific binding. Some ELLA methods 
similarly use BSA in lectin probing solutions (29, 33). However, having demonstrated 
that many lectins can interact with glycosylated contaminants in BSA solutions, there 
is the possibility that inclusion of BSA in lectin probing solutions could quench 
interactions with the desired immobilized glycoprotein targets resulting in false 
negatives. This inhibitory effect was explored by immobilizing 50 ng of the 
glycoprotein Fetuin in the wells of ELISA plates and the wells were subsequently 
blocked with 0.5% PVA. Wells were then probed with lectin solutions with or without 
BSA included to final concentrations of 1% or 3%. Lectins were additionally incubated 
with inhibiting sugars to demonstrate that observed lectin-glycoprotein interactions 
were glycan mediated. When the plates were developed it was evident that signal 
strengths were affected by the presence of BSA in the probing solutions (Figure 9).  
AIA and WGA signals were abolished by both 1% and 3% BSA, while the SNA signal 
degreased with an increase in BSA concentration. The ConA signal strength was not 
significantly impacted by the presence of the BSA. This experiment clearly 
demonstrated that the inclusion of untreated BSA in lectin probing solutions can 
reduce the magnitude of the signal strength, thereby reducing the sensitivity of the 
assay and potentially resulting in false negative results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
One of the key steps in any ELISA is the blocking step. After immobilization of a 
target molecule to a surface, unoccupied sites on the plate surface must be blocked off 
prior to addition of subsequent probing protein solutions. If this is not done non-
specific interactions between the probing biomolecules with the plate surface lead to 
false positive signals or masking of true signals. This blocking step is equally 
important in performing ELLA analysis, but unlike standard ELISA assays appropriate 
blocking procedures are still ill defined in the literature. Many of the blocking agents 
described to date are only suitable for limited subsets of lectins. As a result most 
methods reported to date are limited in their utility and the breath of analysis that can 
be performed. We therefore sought to investigate and compare a range of blocking 
agents with the aim of establishing a generic protocol applicable to performing analysis 
with a broad spectrum of lectins. 
 
Many ELISA protocols commonly use BSA solutions as blocking reagents, typically at 
concentrations of 0.5% to 5% (w/v). This use of BSA has also been reported in ELLA 
protocols in the literature (29, 33). In this study we demonstrated that when BSA is 
used to block plates in ELLA’s, false positives can become a major problem (see 
Figure 2). In assay control wells, which were coated with BSA blocking solution only, 
high signals were consistently observed for certain lectins and interestingly these 
lectins could be grouped according to sugar specificity. ConA and LCA, which are 
reported to bind to the mannose core of N-linked glycans, were both observed to 
exhibit high binding to the BSA preparations, while NPL and GNL, which are reported 
to bind to terminal mannose, did not appear to interact at all. The sialic acid binding 
lectins in the test-set, SNA, MAL II and WGA, were also observed to interact strongly 
with BSA blocked wells. These lectins encompass key specificities that researchers 
would want to screen for in ELLA’s but the observed interactions with BSA blocked 
wells would preclude the use of these lectins in ELLA’s where BSA was used as a 
blocking agent. 
 
We demonstrated that specific lectin interactions with BSA blocked wells could be 
inhibited if the lectin was pre-incubated with its preferred sugar ligand before being 
added to the wells (see Figure 3). If mixed with an alternative sugar no inhibition was 
observed. This sugar specific inhibition of lectin interactions, in addition to the 
observation that defined specificity groups of lectins had displayed reactivity to BSA 
blocked wells, indicated that the signals were due to specific lectin-glycan interactions 
and not due to non-specific protein-protein interactions. Since BSA itself is known not 
to be glycosylated (37) we believed that the interactions were not with BSA itself but 
with contaminating glycoproteins present in BSA preparations. The presence of 
contaminating glycoproteins in BSA preparations was confirmed by performing lectin 
pull down assays on BSA preparations. Using ConA and AAL agarose resins, 
contaminating glycoproteins were effectively purified from BSA preparations (see 
Figure 4). When sugar eluted fractions were examined by SDS-PAGE, the ConA 
eluted fraction in particular showed multiple strong bands. The major band visible is 
likely to correspond to the heavy chain of purified γ-globulins (IgG) which is known to 
be a major contaminating species in BSA preparations. However, several other strong 
bands were also observed indicating the presence of additional significant glycosylated 
contaminants. The AAL eluted fraction contained fewer purified proteins and resulted 
in weaker bands on SDS-PAGE. However, some of the bands observed were of the 
same molecular mass as those observed in the ConA eluted fraction. 
 
For BSA to be an effective blocking reagent, applicable to a broad range of lectins in 
ELLA’s, a highly purified preparation would be required. Therefore, we decided to 
assess a number of commercially available preparations of BSA to try and identify one 
that might be suitable for use direct use in ELLA’s. Three different BSA preparations, 
all available from Sigma-Aldrich, were examined (see Figure 5). BSA is primarily 
produced by heat treatment and alcohol precipitation from serum, resulting in purity 
levels of 96-98% (41). BSA96 is purified by heat treatment and organic solvent 
precipitation only, and the major contaminants listed are globulins. The γ-globulin, 
IgG, is one of the most common proteins in serum after albumin and would represent 
one potential glycosylated contaminant. BSA98 is further processed to remove lipid 
and low molecular weight substances and also contains contaminating globulins. When 
these two BSA preparations were subjected to ELLA analysis, they both exhibited very 
similar lectin responses, and can be assumed to be comparable in terms of glycan 
content. The ELISA grade BSA is processed to be essentially free of fatty acids and γ-
globulins but it still generated significant signals against the same lectins as the other 
BSA samples tested (see Figure 5). This confirmed that the interaction of lectins with 
BSA preparations was only partly due to the presence of contaminating globulins and 
that a large proportion of the observed signals were due to the presence of additional 
contaminating glycosylated proteins. This was therefore consistent with the results 
obtained in the lectin pull down assays with ConA which showed the presence of 
multiple contaminating glycoprotein species. While the observed signals against the 
ELISA grade BSA were slightly lower than those observed against BSA96 and 
BSA98, they were still of such a magnitude that the ELISA grade BSA would not be 
suitable for use in broad spectrum ELLA analysis.  
 
Sodium periodate treatment can be used to oxidize the sugars present on glycoproteins 
thereby preventing interactions with lectins. We evaluated the utility of this method for 
the preparation of deglycosylated BSA (deBSA). The treatment was found to be quite 
effective; dramatically decreasing background signals for most of the lectins tested and 
confirming that most of the lectins that had showed interactions with the BSA had 
done so in a sugar specific manner (see Figure 6). Of the 19 lectins tested, only 3 (AIA, 
WGA and DSL) showed residual binding to deBSA (42). Periodate treatment is 
relatively simple to perform and can be scaled for bulk preparation of BSA blocking 
solutions. It could also be performed on the lower grades of BSA to further reduce 
costs if necessary. Some protein precipitation was observed during incubation of BSA 
with the sodium periodate but as BSA solutions were diluted prior to use, this did not 
affect the reproducibility of the assay  
 
We also evaluated methods that reported the omission of blocking steps (26). These 
methods simply include Tween 20 in lectin probing solutions. While we found this 
method to be more suitable for a broader spectrum of lectins than those using BSA 
blocking steps, some of the most commonly used lectins, such as ConA, AAL, DSL 
and AIA, still exhibited very high background signals against the unblocked wells.  
These signals were of such a high magnitude that they would preclude the use of these 
lectins in this format. 
 
Having determined that none of the above approaches would entirely enable broad 
spectrum lectin screens we decided to evaluate a number of synthetic blocking agents. 
Synthetic blocking reagents have been successfully used in ELISA and other 
immunoabsorbent assays where BSA was found to be inappropriate (27, 43). In this 
study we examined PVA, PVP and PEG solutions as blocking agents. These were 
initially tested against a subset of lectins comprised of those that had displayed high 
background signals in the other assay protocols. All of the synthetic blockers appeared 
to effectively block plate surfaces for the majority of the lectins tested. Only WGA and 
DSL displayed significant background signals against PVP and PEG blocking agents, 
but none of the lectins tested showed interactions with PVA. PVA was therefore 
selected and used to block plates in an ELLA analysis of three commercially available 
glycoproteins, Fetuin, Invertase and Thyroglobulin. The assay was conducted using 19 
lectins and all of the lectins showed low signals in negative control wells containing no 
glycoprotein. Conversely all of the lectins showed responses to the glycoproteins that 
were consistent with the expected glycan structures known to be present on these 
glycoproteins. For example, the sialic acid binding lectins showed high signals on 
Fetuin and Thyroglobulin, but did not interact with Invertase. Conversely, mannose 
binding lectins interacted strongly with Invertase which is known to contain high 
mannose glycans, but not with Fetuin or Thyroglobulin. ConA and LCA, which have 
been reported to bind to the mannose core structure of N-linked glycans, showed strong 
binding to each of the glycoproteins.  
 
In addition to being used to block unoccupied sites on plate surfaces, BSA is 
commonly included in the probing solutions of ELISA’s and ELLA’s to reduce non-
specific binding. However, glycosylated contaminants present in BSA preparations 
could potentially act as lectin inhibitors, out-competing and quenching interactions 
with surface immobilized target molecules and reducing the sensitivity of the assay. To 
evaluate the potential impact of utilizing BSA in this manner in ELLA’s we performed 
using the glycoprotein Fetuin was immobilized as the target molecule. Wells were 
subsequently blocked with PVA and probed with lectin solutions with 0%, 1% or 3% 
BSA included. All of the lectin-Fetuin interactions were prevented by pre-incubating 
the lectins with their inhibiting sugars, demonstrating that the interactions were 
protein-glycan in nature. The results of the experiments with the BSA solutions varied. 
ConA, which interacted strongly with BSA coated wells, did not vary its signal when 
0%, 1% or 3% BSA was included in the probing solution. This is probably a reflection 
of the strength of the interaction of this lectin with the immobilized Fetuin. In contrast, 
Although AIA and WGA both gave decent signals when there was no BSA in the 
lectin solution, both the 1% and 3% solutions abolished the lectins interaction with the 
Fetuin, suggesting that the lectins interacted more strongly with the contaminants in the 
BSA (or the BSA itself) than they did with the Fetuin. The SNA signal was also 
affected by inclusion of the BSA in the solution. In this case, the signal decreased with 
increasing BSA concentration. These results clearly demonstrated that the inclusion of 
BSA preparations in lectin probing solutions could severely quench the potential signal 
strength thereby reducing the sensitivity of the assay and potentially resulting in false 
negative results.  
 
Commercially available carbohydrate free blocking reagents, such as Synblock (AbD 
Serotec) and Carbo-Free blocking solution (Vector Laboratories), are finding wider use 
for glycoanalytical applications. Under our experimental conditions the Carbo-Free 
blocking solution was observed to exhibit interactions with a small subset of the 19 
lectins tested. We found the Synblock reagent exhibited low overall background 
signals against all of the lectins tested. PVA was found to perform equally as well but 
is significantly cheaper than the commercially available alternatives.  
Ultimately this study therefore presents a global methodology for performing broad 
spectrum lectin based analysis of glycoproteins and glycoconjugates via an ELLA 
methodology implementing PVA as an effective blocking agent and making it possible 
to analyse glycoconjugates in a more thorough manner than had been previously 
possible. 
 
Tables 
 
Table 1. Abbreviations and sugar specificities of the lectins used in this study (6, 28, 
36).  
Lectin Abbreviation Sugar specificity 
Aleuria aurantia AAL Fucose 
Concanavalin A (Canavalia ensiformis) ConA Mannose/Glucosec 
Dolichos biflorus DBA GalNAc 
Datura stramonium DSL GlcNAc/LacNAc 
Erythrina cristagalli ECL Galactose/GalNAc 
Galanthus nivalis GNL Mannose 
Griffonia simplifolia I Isolectin B4 GSL I Galactose 
Griffonia simplifolia Lectin II GSL II GlcNAc 
Jacalin (Artocarpus integrifolia) AIA Galactose/GalNAc 
Lentil Lectin (Lens culinaris) LCA Mannose/Glucosec 
Maackia amurensis Lectin I MAL I LacNAc 
Maackia amurensis Lectin II MAL II Sialyllactose 
Narcissus pseudonarcissus NPL Mannose 
Peanut Agglutinin (Arachis hypogaea) PNA Galactose 
Ricinus communis RCA120 Galactose/GalNAc 
Soybean Agglutinin (Glycine max) SBA GalNAc/Galactose  
Sambucus nigra SNA Neu5Ac 
Ulex europaeus Lectin I UEA I Fucose 
Wheat Germ Agglutinin (Triticum vulgare) WGA Neu5Ac; GlcNAc 
Figures 
 
 
 
Figure 1: Potential Enzyme Linked Enzyme Assay (ELLA) formats.                      
(A) Direct immobilization of glycoprotein targets: Target glycoproteins are 
immobilized by non-specific absorption on the surface of an ELISA plate. Plates are 
blocked and the target glycoproteins are then probed with biotinylated lectins. Bound 
lectins are ultimately detected with labeled Streptavidin or an anti-biotin antibody.      
(B) Affinity capture and immobilization of glycoprotein targets: If an affinity 
molecule, such as a specific antibody, is available for a desired target glycoprotein it 
can be pre-immobilized onto ELISA plate surfaces and the surfaces subsequently 
blocked. The desired target glycoprotein can then be captured and effectively 
immobilized on the antibody functionalised surfaces for subsequent probing with 
lectins. This format allows the selective capture a target molecule from complex 
mixtures but the capture antibody must be deglycosylated prior to use as an assay 
component .  
(A) 
=   HRP Conjugated Anti-Biotin Antibody    =   Target Specific Capture Antibody 
=  Glycoprotein Target = Lectin = Blocking Agent = HRP     = Biotin     
(B) 
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Figure 2: Lectin interactions with BSA blocked surfaces. Nunc MaxiSorp plates were 
blocked with 3% BSA solution to mimic negative controls used in ELLA’s. Of the 19 
lectins tested, nine of them showed strong signals against the BSA blocked wells. It was 
observed that many of the reacting lectins could be grouped according to specific 
carbohydrate binding specificities (A) ConA and LCA which bind to the mannose core 
structure of N-linked glycans (B) WGA, MAL II and SNA are sialic acid binding lectins. 
These interactions therefore collectively indicate the presence of specific glycan’s and that 
the observed interactions are due to specific lectin-glycan interactions rather than non-
specific protein-protein interactions. The magnitude of the observed interactions would 
make BSA an unsuitable blocking agent in ELLA’s using these lectins. 
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Figure 3: Sugar inhibition of lectins interactions 
with BSA blocked surfaces. Incubation of ConA 
and AAL with 50 mM α-methyl mannose and 
50mM fucose, respectively, prior to addition to 
BSA blocked wells resulted in a dramatic decrease 
in signal strength. Similarly, interaction of SNA 
with BSA blocked wells was inhibited by prior 
incubation with glycoprotein Fetuin, known to be 
heavily sialylated. In contrast, incubation of the 
lectins with 50 mM galactose resulted in no change 
in signal strength.  
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Several proteins were eluted from the ConA-Agarose with α-methylmannose. One of the 
strongest bands eluting from the ConA agarose is likely to be the heavy chain of IgG (*). Some 
residual BSA was also observed to elute from the resin (**), potentially as a result of co-
purification with specifically bound glycoproteins. Several of the bands that eluted were also 
observed to elute from the AAL-agarose (X).  
Figure 4: Enrichment of low abundance 
glycosylated species in BSA preparation using 
ConA-Agarose and AAL-Agarose: Lanes 1 & 
11: Molecular weight markers; Lane 2: BSA 
Preparation; Lane 3: ConA unbound material; 
Lane 4: ConA α-methylmannose-eluted species; 
Lane 5: Residual material released from ConA-
Agarose by boiling; Lane 6: Boiled ConA-
Agarose control; Lane 7: AAL unbound material; 
Lane 8: AAL fucose-eluted species; Lane 9: 
Residual material released from AAL-Agarose by 
boiling; Lane 10: Boiled AAL-Agarose control.  
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Figure 5. Evaluation of BSA purity grades for application in ELLA’s. The wells 
of ELISA plates were blocked with three different commercially available purity 
grades of BSA and probed with an extensive panel of lectins. Negative control wells 
were not blocked prior to probing with lectins. Several lectins displayed strong 
interactions with unblocked wells (AAL, ConA, AIA and DSL). Additional lectins 
also showed lower but significant responses, around 0.2 AU, against unblocked wells 
(UEAI, NPL, GNL and WGA). Many lectins displayed very strong signals against all 
grades of BSA tested, including ELISA grade BSA. This demonstrated that using 
BSA, or unblocked wells, was not an effective strategy for reducing background for 
all lectins in the test set.  
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Figure 6. Comparison of the responses of lectins to ELISA plate surfaces blocked with 
deglycosylated BSA (deBSA). Oxidation of the contaminating glycans in the BSA preparations 
by sodium periodate treatment prior to use in blocking plate surfaces eliminated the interaction of 
the majority of the lectins with plate surfaces. Only three of the lectins tested (AIA, WGA and 
DSL) continued to interact with deBSA blocked surfaces, and this may be because of protein-
protein interactions occurring (42) 
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Figure 7: Evaluation of synthetic blocking reagents for use in ELLA’s. (A) Four synthetic 
polymers were used to block the wells of ELISA plates which were then probed with a broad 
spectrum of lectins. All of the synthetic agents tested effectively blocked surfaces for the majority of 
the lectins. However, PVP was found to be unsuitable for use with the lectins WGA, ConA, AAL, 
AIA and DSL. The lectin WGA was also found to interact with PEG blocked wells. PVA acted as 
the best blocking agent and did not interact significantly with any of the lectins tested. (B) ELLA 
analysis was performed on the glycoproteins Fetuin, Invertase and Thyroglobulin using PVA as a 
blocking agent. No significant background signals were observed for any of the lectins used. Each of 
the lectins interacted with the glycoproteins in a manner that was consistent with the glycan 
structures expected to be present on the surface of the glycoproteins. 
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Figure 8. Evaluation of commercially available blocking reagents. The commercial blocking 
reagents Synblock produced by AbD Serotec and Carbo-Free blocker produced by Vector 
Laboratories were evaluated in ELLA’s. Like PVA, Synblock was found to be a suitable reagent 
for blocking plates in ELLA’s since none of the lectins in the test set interacted with Synblock 
coated wells. However, although acted as an effective blocking reagent for the majority of the 
lectins tested, several of the lectins in the set (AIA, MAL II, SNA, DSL and SBA) interacted with 
the Carbohydrate free blocking reagent, making this reagent unsuitable for use in assays utilizing 
these particular lectins. 
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Figure 9. Effect of including BSA in lectin probing solutions. BSA is commonly used in 
multiwell plate assays to prevent non-specific binding, but the contaminants in the BSA 
preparations may have undesirable effects in ELLA’s. To examine this, Fetuin was immobilized on 
a plate surface and blocked with PVA. Lectin solutions were prepared in TBST, 1% BSA in TBST 
or 3% BSA in TBST and added to the wells of the plate. Wells without Fetuin were used as 
controls. Fetuin was additionally probed with lectin solutions containing inhibiting sugars specific 
to each lectin used to ensure that any signals observed on were due to interactions with the glycan 
component of the Fetuin. When the plate was developed it was observed that the presence of BSA 
diminished the signal strength of each lectin tested, and in the cases of AIA and WGA abolished 
the signal completely. It is therefore better to prepare solutions without BSA in ELLA’s to 
maximize the sensitivity of the assay. 
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